1 Min Read
NEW YORK, Nov 28 (Reuters) - Vermillion Inc : * Jumps 45.4 percent to $1.73 after medical journal Gynecologic Oncology published clinical study results of the company’s ovarian cancer test
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.